News & Events

≪ Back to All News & Events

October 18, 2010

Noxilizer to Present at AdvaMed 2010 and Mid-Atlantic Bio

Noxilizer to Present at AdvaMed 2010 and Mid-Atlantic Bio

Noxilizer technology to be presented to health care leaders and investors.

(Baltimore, MD — October 18, 2010) Noxilizer, Inc. has been selected to present at two of the leading health care meetings: AdvaMed 2010 and Mid-Atlantic BIO. The presentation at AdvaMed 2010 will be on October 20, 2010 at 9:30am in Room 204A during the international meeting being held at the Walter E. Washington Convention Center in Washington, DC. Noxilizer’s presentation at Mid-Atlantic BIO will be on October 28th at 10am at the Bethesda North Marriott in Bethesda, MD.

“ To be selected to present at these two prominent meetings of medical device and biotechnology leaders is a huge compliment to Noxilizer and further validates our enabling technology,” says Lawrence Bruder, Noxilizer’s President & CEO.

Noxilizer has developed the first new low temperature sterilization technology in over 15 years. The company is targeting two large markets: hospitals and life science manufacturing. Mr. Bruder continues, “Every month, we receive calls from companies that have developed the next generation bioresorbable implant or sophisticated endoscope and they are not satisfied with current sterilization options. The Noxilizer sterilization technology may provide a new option for these companies and support continued innovation.”

About Noxilzer, Inc.:
Noxilizer is pioneering the development of a unique and superior sterilization technology that will revolutionize two major sterilization markets — hospitals and life science manufacturing. In hospitals, Noxilizer is developing a system especially for the sensitive high-tech equipment increasingly used in minimally invasive surgical procedures. In the life science market, the development of next generation therapies and medical devices is constrained by current sterilization technologies. Noxilizer’s advantages include: more gentle and lethal sterilization, safe for workers and the ability to sterilize long lumens used in minimally invasive surgery and other procedures. Noxilizer is committed to providing innovative solutions for healthcare professionals and their patients. The company was founded in 2004 and is privately held. Noxilizer is located at the University of Maryland Baltimore County Technology Center in Baltimore, MD. For more information, visit: www.noxilizer.com.

About AdvaMed 2010:
AdvaMed 2010 is the premier MedTech conference for business leaders, entrepreneurs, policy-makers, media, financiers, and other industry stakeholders from around the world. In only its third year, AdvaMed 2009 attracted 1,400 industry leaders – including 500+ CEOs, Presidents and C-level executives. In today’s economic and political climate, AdvaMed 2010 is this year’s can’t miss MedTech event for networking; conducting partnering meetings; influencing policymakers and the media; and participating in educational sessions. Whether you need to finance, partner, or license technology; learn the latest important developments in reimbursement, regulatory, legal, intellectual property, and other critical areas; or meet with and hear from leaders in the Obama Administration and Congress, AdvaMed 2010 is your introduction to key decision-makers. For more information, visit http://www.AdvaMed2010.com.

About Mid-Atlantic BIO
The Mid-Atlantic Bio Conference, scheduled October 27-29, 2010, in Bethesda, Maryland, is co-hosted by the Tech Council of Maryland (TCM), the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO). Mid-Atlantic Bio benefits from broad regional support from the investor and greater business communities, academic institutions, government agencies, and partnering regional associations. For more information, or to register or sponsor, please visit www.midatlanticbio.org.